Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

NCT01531205 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Prostate Cancer

Interventions

DRUG: Androgen Ablation
DRUG: Cabazitaxel
DRUG: Salvage Therapy
DRUG: Neoadjuvant Treatment - Hormonal Therapy
DRUG: Neoadjuvant Treatment - Cabazitaxel

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]